JOANN BUHR COTE: Open Payments
NPI 1881812691 · PAYETTE, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,026 in 68 payments from 17 companies in 2025. Trend: 2023 $389 · 2024 $710 · 2025 $1,026
Food & beverage: $1,026
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 24 | $273 |
| Vanda Pharmaceuticals Inc. | 11 | $150 |
| Novo Nordisk Inc | 6 | $114 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $97 |
| Otsuka America Pharmaceutical, Inc. | 5 | $89 |
| Novartis Pharmaceuticals Corporation | 3 | $49 |
| Alkermes, Inc. | 2 | $38 |
| PFIZER INC. | 2 | $36 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $29 |
| Axsome Therapeutics, Inc. | 1 | $27 |
Products named: VRAYLAR, FANAPT, CAPLYTA, Ozempic, UBRELVY, REXULTI, LEQVIO, LYBALVI.
Industry payments across ID — which companies pay providers there.
